Filing Details
- Accession Number:
- 0001140361-10-011607
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-12 12:00:00
- Reporting Period:
- 2010-03-10
- Filing Date:
- 2010-03-12
- Accepted Time:
- 2010-03-12 16:27:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1427842 | J Peter Dailey | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Svp, Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-03-10 | 15,000 | $9.02 | 20,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-03-10 | 15,000 | $19.50 | 5,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-03-10 | 15,000 | $0.00 | 15,000 | $9.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,000 | 2013-06-12 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2009.
- 5,000 shares are subject to a right of repurchase, which right lapses as to one-half of the shares on January 23, 2011 and the balance on January 23, 2012.
- 25% of the shares subject to the grant vested and became exercisable on June 12, 2007 and 2.0833% of the shares vest and are exercisable on each monthly anniversary of the First Vesting Date until 100% vested.